{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:01:43Z","timestamp":1791910903394,"version":"4.3.4"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T00:00:00Z","timestamp":1397001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0094475","type":"journal-article","created":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T21:05:10Z","timestamp":1397077510000},"page":"e94475","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Immune Dysregulation as a Cause of Autoinflammation in Fragile X Premutation Carriers: Link between FMRI CGG Repeat Number and Decreased Cytokine Responses"],"prefix":"10.1371","volume":"9","author":[{"given":"Milo","family":"Careaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Destanie","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi","family":"Hagerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ashwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1086\/302720","article-title":"Elevated Levels of <italic>FMR1<\/italic> mRNA in Carrier Males: A New Mechanism of Involvement in the Fragile-X Syndrome","volume":"66","author":"F Tassone","year":"2000","journal-title":"The American Journal of Human Genetics"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-3-642-21649-7_18","article-title":"The fragile X-associated tremor ataxia syndrome","volume":"54","author":"F Tassone","year":"2012","journal-title":"Results Probl Cell Differ"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.celrep.2013.02.004","article-title":"Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor\/ataxia syndrome","volume":"3","author":"C Sellier","year":"2013","journal-title":"Cell Rep"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuron.2013.03.026","article-title":"CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome","volume":"78","author":"PK Todd","year":"2013","journal-title":"Neuron"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.biopsych.2011.05.033","article-title":"Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation","volume":"70","author":"D Hessl","year":"2011","journal-title":"Biol Psychiatry"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/gme.0b013e3181a06a37","article-title":"Premature ovarian failure and fragile X female premutation carriers: no evidence for a skewed X-chromosome inactivation pattern","volume":"16","author":"L Rodriguez-Revenga","year":"2009","journal-title":"Menopause"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/humrep\/deh635","article-title":"Association of FMR1 repeat size with ovarian dysfunction","volume":"20","author":"AK Sullivan","year":"2005","journal-title":"Hum Reprod"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(95)92194-X","article-title":"Fragile X premutations in familial premature ovarian failure","volume":"346","author":"GS Conway","year":"1995","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1096-8628(19990528)84:3<300::AID-AJMG27>3.0.CO;2-5","article-title":"Premature ovarian failure (POF) and fragile X premutation females: from POF to to fragile X carrier identification, from fragile X carrier diagnosis to POF association data","volume":"84","author":"ML Uzielli","year":"1999","journal-title":"Am J Med Genet"},{"key":"ref10","first-page":"127","article-title":"Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology","volume":"57","author":"RJ Hagerman","year":"2001"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Tassone F, Berry-Kravis EM (2010) The fragile X-associated tremor ataxia syndrome (FXTAS): Springer.","DOI":"10.1007\/978-1-4419-5805-1"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/ejhg.2009.51","article-title":"Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families","volume":"17","author":"L Rodriguez-Revenga","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ajmg.b.30786","article-title":"Mood and anxiety disorders in females with the FMR1 premutation","volume":"150B","author":"JE Roberts","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4088\/JCP.09m05407blu","article-title":"Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers","volume":"72","author":"JA Bourgeois","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ajmg.a.32060","article-title":"Expanded clinical phenotype of women with the FMR1 premutation","volume":"146A","author":"SM Coffey","year":"2008","journal-title":"Am J Med Genet A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/ajmg.a.35323","article-title":"Hypertension in FMR1 premutation males with and without fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"158A","author":"AA Hamlin","year":"2012","journal-title":"Am J Med Genet A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/ajmg.a.35569","article-title":"Immune-mediated disorders among women carriers of fragile X premutation alleles","volume":"158A","author":"TI Winarni","year":"2012","journal-title":"Am J Med Genet A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1742-2094-9-238","article-title":"Carriers of the fragile X mental retardation 1 (FMR1) premutation allele present with increased levels of cytokine IL-10","volume":"9","author":"D Marek","year":"2012","journal-title":"J Neuroinflammation"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2310\/JIM.0b013e3181af59d6","article-title":"Mouse models of fragile X-associated tremor ataxia","volume":"57","author":"RF Berman","year":"2009","journal-title":"J Investig Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1086\/374321","article-title":"Fragile X premutation tremor\/ataxia syndrome: molecular, clinical, and neuroimaging correlates","volume":"72","author":"S Jacquemont","year":"2003","journal-title":"Am J Hum Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/hmg\/ddg114","article-title":"The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor\/ataxia syndrome","volume":"12","author":"R Willemsen","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2353\/jmoldx.2008.070073","article-title":"A Rapid Polymerase Chain Reaction-Based Screening Method for Identification of All Expanded Alleles of the Fragile X <italic>FMR1<\/italic> Gene in Newborn and High-Risk Populations","volume":"10","author":"F Tassone","year":"2008","journal-title":"The Journal of Molecular Diagnostics"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1373\/clinchem.2009.136101","article-title":"A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome","volume":"56","author":"S Filipovic-Sadic","year":"2010","journal-title":"Clin Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/hmg\/ddp479","article-title":"Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration","volume":"19","author":"Y Chen","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s10875-004-6241-6","article-title":"Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10","volume":"24","author":"P Ashwood","year":"2004","journal-title":"J Clin Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbi.2008.08.001","article-title":"Altered gene expression and function of peripheral blood natural killer cells in children with autism","volume":"23","author":"AM Enstrom","year":"2009","journal-title":"Brain Behav Immun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbi.2009.08.001","article-title":"Differential monocyte responses to TLR ligands in children with autism spectrum disorders","volume":"24","author":"AM Enstrom","year":"2010","journal-title":"Brain Behav Immun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/08959374960100011101","article-title":"The association between immunodeficiency and the development of autoimmune disease","volume":"10","author":"JW Sleasman","year":"1996","journal-title":"Adv Dent Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaut.2010.06.008","article-title":"The odd couple: a fresh look at autoimmunity and immunodeficiency","volume":"35","author":"IR Mackay","year":"2010","journal-title":"J Autoimmun"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-3083.2010.02386.x","article-title":"Primary immunodeficiency and autoimmunity: lessons from human diseases","volume":"71","author":"GJ Arason","year":"2010","journal-title":"Scand J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12016-012-8345-8","article-title":"Tolerance and autoimmunity in primary immunodeficiency disease: a comprehensive review","volume":"45","author":"S Gupta","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molmed.2011.10.005","article-title":"Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus","volume":"18","author":"AP Grammatikos","year":"2012","journal-title":"Trends Mol Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.03.026","article-title":"Biomarkers of disease activity in multiple sclerosis","volume":"305","author":"JJ Graber","year":"2011","journal-title":"J Neurol Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/1529-0131(199805)41:5<838::AID-ART10>3.0.CO;2-S","article-title":"Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus","volume":"41","author":"DA Horwitz","year":"1998","journal-title":"Arthritis Rheum"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2249.1997.d01-1009.x","article-title":"IL-12 inhibits in vitro immunoglobulin production by human lupus peripheral blood mononuclear cells (PBMC)","volume":"108","author":"FA Houssiau","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6878","DOI":"10.4049\/jimmunol.161.12.6878","article-title":"Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL\/++ and New Zealand Black\/White F-1 lupus-prone mice and the Leishmania major-susceptible BALB\/c strain","volume":"161","author":"DG Alleva","year":"1998","journal-title":"Journal of Immunology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"SL Deshmane","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ajmg.b.32065","article-title":"Prevalence of CGG expansions of the FMR1 gene in a US population-based sample","volume":"159B","author":"MM Seltzer","year":"2012","journal-title":"Am J Med Genet B Neuropsychiatr Genet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0094475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:28:30Z","timestamp":1689121710000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0094475"}},"subtitle":[],"editor":[{"given":"Bernhard","family":"Ryffel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,9]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0094475","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,9]]}}}